Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the impact of the COVID-19 pandemic on the treatment of patients with multiple myeloma. Dr Ghobrial discusses the benefits and limitations of telemedicine on patient care and how this could affect therapeutic approaches in the future. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.